Becker's Healthcare March 11, 2022
Pfizer has completed its acquisition of Arena Pharmaceuticals, a drugmaker developing potential treatments for several immuno-inflammatory diseases.
Pfizer acquired Arena for $100 per share in an all-cash transaction valued at about $6.7 billion, the companies said in a March 11 news release.
Arena’s lead drug candidate is etrasimod, an oral treatment being tested to treat inflammatory bowel diseases.
“We are excited to add the impressive experience and pipeline of...
Today's Sponsors
Today's Sponsor